HWM
NVO

Hemington Wealth Management’s Novo Nordisk NVO Stock Holding History

Hemington Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$14K Buy
266
+48
+22% +$2.81K ﹤0.01% 772
2025
Q2 		$15K Hold
218
– – ﹤0.01% 725
2025
Q1 		$15K Hold
218
– – ﹤0.01% 670
2024
Q4 		$18K Sell
218
-117
-35% -$12.7K ﹤0.01% 580
2024
Q3 		$37K Buy
+335
New +$44.7K 0.01% 362
2024
Q1 		– Sell
-2,000
Closed -$207K – 118
2023
Q4 		$207K Buy
+2,000
New +$198K 0.08% 100

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hemington Wealth Management's NVO Position: Q3 2025 in Review

Hemington Wealth Management increased its Novo Nordisk (NVO) stake by 22% in Q3 2025, buying an estimated $2.81K and bringing the position to 266 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #772.

Hemington Wealth Management first reported a position in NVO in Q4 2023 and has held it in 6 quarters since. The position peaked at $207K in Q4 2023. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Hemington Wealth Management held 266 shares of Novo Nordisk worth $14K as of Q3 2025.
  • Hemington Wealth Management bought 48 Novo Nordisk shares in Q3 2025, an estimated $2.81K.
  • Novo Nordisk made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #772 holding.
  • Hemington Wealth Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 6 quarters since.
  • Hemington Wealth Management's Novo Nordisk position peaked at $207K in Q4 2023.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.